Stem cell tourism is criticized on grounds of consumer fraud, blatant lack of scientific justification, to medically hmvative m-e may be prefemble to
and patient safety. However, the issues are complex because they invoke questions concerning the enrohg in a clinical trial, =pially where &ent
Lirnib of acceptable medical innovation and medical travel. Here we discuss these issues and care is decidedly not the purpose of the triak
articulate conditions under which "unproven" therapies may k offered to patients outside of expanding howledge is. Patients with pwcious
regular clinical trials.
Wednesday, August 5, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment